The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies.
about
The Role of PARP Inhibitors in the Treatment of Gynecologic MalignanciesMicroRNAS in endometrial cancer: recent advances and potential clinical applicationsEndometrial cancer: what is new in adjuvant and molecularly targeted therapy?Familial cancer among consecutive uterine cancer patients in Sweden.GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptorCirculating MicroRNAs in gynecological malignancies: from detection to predictionMGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer casesMolecular profiling of endometrial malignancies.Genetics of endometrial cancersLoss of CDH1 and Pten accelerates cellular invasiveness and angiogenesis in the mouse uterus.Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experienceRapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment.ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression.MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location.Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.A mechanism for synergy with combined mTOR and PI3 kinase inhibitors.Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.Prognostic significance of miR-205 in endometrial cancer.Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinomaVisual gene-network analysis reveals the cancer gene co-expression in human endometrial cancerSignalling pathways in endometrial cancerAberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor.Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancerExercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetesScreening for germline phosphatase and tensin homolog-mutations in suspected Cowden syndrome and Cowden syndrome-like families among uterine cancer patients.Therapeutic advances in women's cancersInfluence of AKT on progesterone action in endometrial diseases.Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironmentLncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells.Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer.A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotypeAn Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.SOX17 increases the cisplatin sensitivity of an endometrial cancer cell linemiR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer.Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibodyPersonalized care in uterine cancer.Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer
P2860
Q21129302-2C77A819-84A5-4260-BB5F-3F287E165A8AQ26780358-053489F7-A14F-4CE4-97FF-482E269BFA54Q33633962-FEB045D9-E5DF-49C0-9BA8-0CF8F11676F1Q33646157-2ED76790-9CBC-4F4A-82C5-65FB9C86B4DEQ33663674-3653575B-AB12-4A0D-8EDF-C8D5D634A56DQ33718986-B9220091-A237-4E1B-8B75-7EC8EC7420E2Q33750187-A98D522B-59F5-4AFA-BEA7-FA38357AA0ADQ33757898-DB9677C8-AB0B-413B-A2BA-41726C96AC44Q33781274-C98390D2-CCBB-45B9-A55F-E0D5BEA057C4Q33826091-60761C2D-D9C4-4F42-A090-C63B24AD334EQ33882527-A9CF9EF7-F40D-4765-B5BD-A6E0C6EA8688Q33894047-7B35B582-9394-40A0-822B-0CE3A52851CFQ33899157-73129708-C388-4885-B7FA-3E828649FCA7Q33903478-09454902-A357-4E9E-8369-7154B731F51EQ33911196-E51832A9-8B73-4605-B12A-0F9E64EF2099Q33981906-C67F86F2-795B-4F92-BAF0-D8EA9387C629Q33991653-254F3A70-620A-448E-8034-B3DB7F83AF15Q34062367-C0285177-A8AC-4696-B338-4B9D29F528FAQ34179949-91000BE1-F7FB-4540-B63F-EDA8C29C4A91Q34238901-39076ACB-FAA3-425E-A936-18875807E17DQ34393036-D36602E3-1D08-426D-AAFF-2A2495BE099EQ34525508-4FE3961C-3C3F-433C-B012-0023C68B9FD4Q34721660-A1297351-4D63-490E-94F4-FE8D93B47D09Q34819689-DA8315DF-C027-4917-B088-2B0B822A403EQ35006823-4AEEB5F3-8FAC-4CE6-B462-4EEE686D2475Q35015365-398F4DF1-F089-4700-9C23-F135C901977DQ35167887-FE2C6B7C-C255-4003-89F6-FA1453712FAAQ35418973-902DFDC9-E829-401B-8363-687DF9CF2778Q35617565-7B7C3828-BECD-4AEC-BDA4-168EACA1A307Q35833089-97E90130-A030-4321-AEA2-271C507C4D18Q36000984-7FFC71A2-90E8-4746-8B93-E649825B04FAQ36223500-6EDB4F16-4642-4269-909A-403FBCA1AD55Q36418630-B808C267-6B0C-4C6F-B8B1-8F2D2D43291AQ36446984-33D41D8D-D4B3-448B-970F-CCF58DFA3FF5Q36600227-A15FC8A4-7E8A-4B6B-834D-0F473503506CQ36783398-08359224-8A27-4CA3-89DF-FFEE56F02E1CQ36905274-C8C0574C-28EB-4C49-A60A-8CFEC5B15FAEQ36949302-AF3A88E7-0E70-4903-9F4D-895FB19967EDQ37006856-7277E3EE-C9CA-42B0-9A37-1ABF87B01067Q37007297-B8000DA2-8EA9-46E5-97B7-470A9440FD50
P2860
The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The molecular biology of endom ...... ation, and targeted therapies.
@en
The molecular biology of endom ...... ation, and targeted therapies.
@nl
type
label
The molecular biology of endom ...... ation, and targeted therapies.
@en
The molecular biology of endom ...... ation, and targeted therapies.
@nl
prefLabel
The molecular biology of endom ...... ation, and targeted therapies.
@en
The molecular biology of endom ...... ation, and targeted therapies.
@nl
P2093
P2860
P1433
P1476
The molecular biology of endom ...... ation, and targeted therapies.
@en
P2093
Nisha Bansal
Robert M Wenham
Vimala Yendluri
P2860
P356
10.1177/107327480901600102
P577
2009-01-01T00:00:00Z